-
Oral antiarrhythmics have limited efficacy and significant risks
- Catheter ablation is now a first-line option in suitable patients
-
Newer ablation technology - Pulsed field ablation (PFA) is safer and faster
-
Anticoagulation decisions remain based on stroke risk, not ablation status
- Genuine post-procedural issues may be benign
- Ongoing healthcare professional role - Blood pressure and risk factor control
The questions answered in this podcast are listed below.
They were compiled by GPs and health professionals around Australia who attended Healthed’s face-to-face seminars.
- How effective are oral antiarrhythmic medications?
- Does this cure atrial fibrillation?
- What is the current state of ablation technology?
- Can you explain what you mean by "rapid" and provide an example of how long a procedure typically takes?
- Does reduced scarring decrease the likelihood or complexity of needing a repeat ablation?
-
What are some of the contraindications in terms of structurally abnormal heart that would be contraindications for the patient?
- How should atrial fibrillation be approached in patients with severe ischaemic heart disease? Does this complicate treatment?
- If a patient has an AF ablation, can they come off my anticoagulant?
- How do you manage patient’s embolic issues?
- How soon after the procedure can patients typically be discharged?
- Following successful AF suppression, is it possible for patients to stop taking DOACs or other anticoagulants?
- After discharge, how soon should patients follow up with their GP?
- What should the GP monitor and what should be communicated back to the specialist?
- When will you consider AV node ablation and insertion of a pacemaker?
Host: David Lim | Total Time: 44 mins
Expert: Prof Rukshen Weerasooriya, Sub-specialist Cardiac Electrophysiologist
Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEST
Click here to register for the next one
See omnystudio.com/listener for privacy information.